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I

Advances in human gene editing have raised considerable attention among researchers, regulators, and the public in recent
months. In this paper, I begin by offering a brief account of both the
"tools of the trade" and the main applications of human gene editing.
Then I describe recent efforts toward the formation of international
guidelines. I conclude with some reflections on ethics at the edge of
science.
Genetic engineering has come a long way in the past 40 plus
years. The latest laboratory tools- zinc finger nuclease, TALEN, and
CRISPR Cas9 - allow researchers to make precise deletions and substitutions along the genomes of any species. Among these tools,
CRISPR Cas9 has garnered the most attention in recent months because it offers by far the fastest and easiest means to edit genes. 1 Anyone can learn to use it in one day.
The CRISPR system is a naturally occurring acquired immune
system found in bacteria and archaea. It allows single-cel l organisms
In the past few months, hundreds of news articles have appeared aro~md the world
in the popular and scientific press about the CRISPR revolution, including this Ne w
York Times i\1/agazine piece, "The CRlSPR Quandary," NYT Magazine, N ovember
9, 2015: http ://www.nytimes.com/20l5/ llll5/magazine/the-crisprq uandary .htm I?_ r=O.
1
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to cut and deactivate foreign genetic elements introduced by invading
viruses and plasm ids. Researchers discovered a couple of years ago
that a specific nuclease (enzyme) in the CRJSPR system, Cas9, could
be used to add, silence, or alter DNA at any location by using the
proper guide RNAs to target the desired sequence. CRISPR Cas9 is
so precise that it can even be used to edit a single base pair within a
gene . Now other CRISPR nucleases are being discovered that could
broaden the genetic engineering toolkit even further. 2
Lately scientists have been using CRISPR Cas9 and other
gene editing technologies experimentally to modify the somatic
(body) cell DNA of individuals suffering from serious genetic diseases. Most recently, an infant suffering from a rare and aggressive form
of leukemia was treated in London using "off the shelf' T cells that
were genetically modified using TALEN to enable them to hide from
her own immune system. By all accounts, she is doing very well. 3 In
another study reported in Science, researchers were able to use
CRISPR to heal mice affected with Duchenne muscular dystroph y
(DMD), allowing the animals to make an essential muscle protein
called dystrop hin in their muscle stem cells. 4 Without dystrophin to
strengthen and protect muscle fibers, people with DMD die by around
age 25 . With more precise gene editing tools at their di sposal, sc ientists are starting to believe that the full promi se of somatic cell "gene
therapies" might finally be within reach. In recogniti on of these rapid
and important advances, Science has hail ed CRlSPR as the 2015
Breakthrough ofthe Year. 5

See Jacob, Julie A. (20 15). "Four New CRISPR Nucleases Characterized," JAMA
3 14 (24): 2607 .
3 "Gene Ed iting Saves Girl Dying From Leukaemia in World First," The Ne111 Scientist , November 5, 2015 .
4
Tabebordbar, M., eta/. (20 15). " In Vivo Gene Ed iting in Dystrophic Mouse Muscle and Muscle Stem Cell s," Science DOl: I 0. 1126/science.aad5177.
5 McNutt, Marcia. (20 15). " Breakthrough to Genome Editing," Science 350 (6267):
1445.
2

2
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Despite the growing excitement over CRISPR application s for
patients, deep-seated ethical and social concerns loom on the horizon.
The first (often overlooked) critical aspect of gene editing involves
the unknown dangers of attempting to use CRISPR nucleases to edit
the genes of living people for their health benefit. As early experience with gene transfer research nearly two decades ago suggests, the
use of genetic engineering interventions during the course of a clinical trial can come with unexpected adverse events, such as was the
case with Jesse Gelsinger, a 19 year-old patient who volunteered for
an early phase safety study of a gene therapy protocol at the University of Pennsylvania. A few days after he entered the study, Gelsinger
died suddenly due to an unanticipated immune reaction to a gene
therapy vector introduced into his liver by investigators. This catastrophic outcome effectively shut down clinical trials of gene transfer
research for many years as the FDA and federal regulators tried to
assess the causes of this event and the steps necessary to minimize the
likelihood of such an occurrence in the future. Another Gelsingerlike adverse event, this time for CRISPR-mediated interventions for
genetic disease, could stall the promise of gene editing for patients for
years if investigators are too cavalier about possible risks. Just because we have already been down the road of somatic cell gene interventions for patients does not mean that this is a road free of potential
pitfalls.
A second, much more scrutinized area of human gene editing
lies its potential effect on future generations. In addition to designing
somatic cell therapies, some researchers have also become interested
in discovering whether CRISPR Cas9 and other nucleases can be used
to alter the human germ line, i.e. , the lineage of cells from which human germ cells (sperm and eggs) are derived. In theory, the human
germ line could be modified by altering the genes of sperm , eggs, or
zygotes. Unlike somatic cell modification s, any changes to the germ
line would be passed to subsequent generations. Where do the ethical
3
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limitations ofthis new technology lie? Some worry that scientists
may be going too far too quickly. The purpose of human germ line
editing would be (at least initially) to replace known harmful genes,
such as the gene responsible for cystic fibrosis , so that parents who
are carriers can avoid transmitting genetic harms to their offspring
while remaining otherwise genetica ll y connected to their children.
For individuals with a family history of a serious genetic disease, one
perceived benefit of human germ line modification would be toremove the threat of the disease for all their descendants. Although society has pondered for decades the possibility of one day creating
"designer babies," first to overcome genetic diseases, then later to include soc ially-desirable genetic traits, recent advances in gene editing
technology have rapidly moved these discussions from the realm of
science fiction toward science reality.
So far, CRISPR-mediated germline editing has been shown to
work in a number of different animal species, including non-human
primates. Transgenic animal models for research can now be generated in just one gestation cycle, as opposed to one year or more using
the previous method of cross-breeding stem cell-derived chimeric animals. Before human germline editing can become a reality, however,
extensive preclinical research in vitro will have to be performed using
human reproductive materials. Currently, most researchers believe
gene editing would have to be applied to a germ cell or a single cell
embryo in vitro in order to avoid genetic mosaicism arising from trying to use CRTSPR Cas9 on multiple cells at once. For this reason ,
the use of surplus fertility clinic embryos (which are stored after the
zygote stage) is not likely to provide a resource for preclinical human
germline editing research . Instead, scientists will have to create their
own embryos for research using donated human germ cells, a form of
research that cannot be federally funded in the U.S. and many other
co untri es at thi s time.
4
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Despite legal restrictions in the U.S. and some oth er countri es
that ·hinder the ease of preclinical human germ line gene editin g research, let alone permit the transfer of genetically-altered embryos
into a womb to produce a pregnancy, some researchers in more permissive jurisdictions, such as China, have repot1ed research using
CRISPR Cas9 to modify human embryos in vitro. Recognizing the
need for international consensus on using CRISPR Cas9 technology
to modify the human genome, particularly with respect to germ line
modifications, an international summit was called in Washington DC
in December 2015 (of which I was a participant). In the meantime,
while scientists and bioethicists are barely beginning their efforts to
draft international guidelines on human gene editing, research teams
in permissive jurisdictions continue their research on modifying the
human germ line and continue to submit their research papers to leading scientific journals (for which I was twice a reviewer).
The advent of CRISPR technology raises two central questions: (I) the scientific question of what can be achieved using this
technology; and (2) the ethical question of how far human gene editing ought to be pursued. The efficien<;ies and precision of CRISPR
technology are improving every day, 6 so these two questions urgently
need to be addressed. At the International Summit on Human Gene
Editing last December, scientists, ethicists, and policy makers agreed
that an ongoing discussion was necessary concerning the many ethical
issues raised by CRISPR technology. The discussants also agreed
that the scientific and ethical questions should be pursued simultane-

ously.
I agree with this conclusion. However, during the course of
the summit, it became apparent that the discussants seemed far more
comfortable talking to one another about the science ofCRISPR and
less at ease delving into the complex ethical issues. Often the discus6

Kleinstiver, B., eta/. (20 16). " High-Fidelity CRJSPR-Cas9 N ucleases With No
Detectable Genome- Wide Off-Target Effects," Nature DOl: l 0.1038/nature 16526.
5
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sants conflated ethical concerns with ("mere") regulatory FDA-level
requirements regarding safety (an important but not ethicallyexhaustive set ofworries). A sustained exploration of the ethical issues surrounding all aspects of human gene editing research is necessary.
We are already at the point where we need to take seriously
the ethics ofthis emerging area of science. The first publication on
human embryo (germline) editing was presented by a group of Chinese scientists in 2015. 7 This form of research immediately raises
four important questions concerning human embryo editing: (1) what
are the technical challenges and how do these challenges impact the
ethics of attempting to use embryo editing in an assisted reproduction
context; (2) what are the clinical and non-clinical (basic science) applications of human embryo editing research ; (3) what are the ethical
issues surrounding the procurement of human gametes and embryos
for gene editing research; and (4) what are the prospects of pursuing
non-reproductive embryo editing without opening the door to reproductive use?
Embryo editing for reproductive purposes is banned in several
countries. Nevet1heless, scientists want to pursue embryo editing research to answer certain questions in developmental biology. These
inquiries include understanding how genes direct early embryonic
development (by using CR!SPR nucleases to turn on and off certain
genes), understanding how non-embryonic cells are formed , and
learning how human germ cells differentiate. Do the scholarly benefits of such intellectual pursuits justify the creation and destruction of
human embryos for research?
This question is complicated by the fact that laws and ethical
expectations differ around the world when it comes to human gene
editing. Some countries, such as the U.S. and the U.K. , have very
7

Liang, P ., et al. , (20 15). "CR.I SPR/Cas9-Mediated Gene Ed iting in Human Tripronuclear Zygotes," Protein and Ce/16 (5): 363-3 72.
6
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strict regulatory standards about the creation of embryos for research
and for the introduction of genetically manipulated cells into patients,
while other countries operate with more lax rules. Furthermore, scientific journal publishing standards for this controversial area of research are still evolving. As the editors of a top-tier scientific journal
recently told me, in the absence of uniform international standards, it
is not clear what editors should do when they receive manuscripts that
describe research which conforms to the authors ' local ethical and
regulatory standards but which falls far short of research ethics standards in the West. CRISPR ethical standards are needed not only for
scientific collaboration internationally, but also for the publication of
research results in top scientific journals.
In the meantime, the recently updated professional and ethical
guidelines ofthe International Society for Stem Cell Research
(ISSCR) can help fill the void in research standards for CRISPRbased genome editing. 8 As mentioned above, germ line editing research in vitro will require the procurement of human gametes, the
creation of embryos for research, and the oversight for embryo research for basic scientific studies at the bench side. The revised
lSSCR guidelines provide guidance for all of these areas, and in that
way the guidelines will provide needed standards for this type of
rsearch internationally, as other scientific societies proceed to draft
more CRISPR-specific professional research standards.
As I reflect on many of the issues raised by the application of
CRISPR technology to the human genome, I cannot help but have a
feeling of inevitability about the prospect of human germ line modifications. The edge of science only cuts forward; it never moves back.
Already we have taken a baby step toward germ line modification for
reproduction: mitochondrial replacement therapies, which would result in heritable changes to future generations, were approved by the
8

Kimmelman, J. , et al. , (20 16). " Scientists Set Global Standards for Stem Cell Research. " Nature 533: 311-313.
7
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U K Parliament last year, with the U.S. Institute of Medicine followin g s uit in an FDA advisory report echoing similar recommendation s
for clinical trials research . If mitochondrial replacement therapies are
approved, then one wonders whether these interventions are really all
that conceptually different from germline modifications that would
occur within the nuclear genome. Wh y should the " geography" of
where the alteration happens in th e germ cell matter ethically?
Ju st as the edge of science always cuts forward , one also may
beg in to wonder whether scientists self-imposed " lines in the sand"
cannot also be redrawn, on occasion, to facilitate where the next cut
in scientific advancement can be achieved. One very timel y example
of this is the current debate over the so-called " 14-day rule" for human embryo research. 9
Human embryo research is permitted, in man y jurisdictions, as
lon g as embryos are maintained in culture for less than 14 consecutive
days of development, and experimentation is concluded before the
appearance of the primiti ve streak (a faint band of cells markin g the
beginning ofthe embryo ' s head-to-tail axis). This 14-day limit is encoded in many countries' laws gove rnin g assisted reproduction and
embryo research. ft is also embod ied in numerou s nati o na l commiss ion reco mmendations and sc ie ntific g uide lines for embryo and assisted reproduction research spannin g nearl y four decades .
As a public po licy instrument, the 14-day rule has been a tremendo us success. lt has offered - at least until now - a clear and lega ll y enforceab le boundary for sc ientific activity. One can count the
number of days an embryo is cu ltured in a dish. The primitive strea k
is somethin g one can actua ll y see. Ad diti o na ll y, the 14-day rule has
the pract ica l virtue of providing a publicly-negotiated approach to
ma nag in g human embryo research, one that is accommodating of
ma ny differing views on th e mo ra l statu s of early e mbryos . The two
o ute rm ost a lternatives to the 14-day rule - of favoring either a zygote
8
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protection position that would disallow embryo research a ltogether or
a lai ssez-faire stance that would impose zero restricti ons on embryo
use - would not have made for good public policy in a pluralistic society.
Under the aegis of the 14-day rule, human embryo research
has flourished. One ofthe most important advances to emerge from
this protected space is human embryonic stem cell research , which
derives cells from 5-day old pre-streak embryos in vitro. Now,
through an ironic twist of fate, a new line of stem cell research - selforganizing embryo-like structures and intact embryo culture- might
begin to challenge the 14-day rule that helped enable its invention.
Some may be unsettled by the prospect of revising this research limit. But the 14-day rule is not unique in this regard. There
are numerous examples of similarly declared limitations averred to
protect the advancement of anxiety-provoking science: yes to humananimal chimera research- but not at the embryo stage; yes to human
cloning for in vitro research - but not for reproduction ; yes to payments for research egg donors ' direct expenses - but not for their
non-financial burdens. Limitations su<;:h as these can be difficult to
maintain in the face of evolving science.
Since it seems to be only a matter of time before human embryo modifications for reproduction become a reality, it is important
to acknowledge that there will always be a role for ethics and philosophical reflection at the edge of science . The prospect of CRISPR
humans raises profound philosophical and ethical questions that traditionally our secular ethical approaches are not very well suited to address. The two main approaches in bioethics today are consequentialist and rights-based moral frameworks. These frameworks, however,
may not be very useful for thinking about the ethics of human
germline modification . Unlike a harm-based or rights-based ethical
approach, which presupposes the existence of either a being that
9

Hyun, L, et al., (20 16). " Rev isit the 14-Day Rule." Nature 533: 169-171.
9
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co uld be harmed by an intervention or a rights-bearer that is wronged,
germline modifications would create a human being who would otherwise not have existed but for the genetic intervention . There is no
being or rights-bearer prior to the intervention, and thus it is not coherent to say that an individual is wronged as a result of gene editing;
his or her only other alternative is non-existence. If embryo editing is
deemed to be morally wrong, then is it because it is wrongfor someone (i.e. because it violates a person-affecting moral principle) or is it
wrong because of some other, non-person-affecting reason. If the latter, then what would be the relevant non-person-affecting moral principle? This conundrum is what Derek Parfit calls the Non-Identity
Problem, which involves the ethics of bringing certain types of people
into existence rather than other types of people, or what Parfit calls
"different people choices." 10
·
Any non-person affecting moral principle up to the task of justifying (or condemning) human germline editing would have to draw
on values that relate to what types of people should be brought into
existence and lay bare what we think these desirable qualities are. I
conclude my thoughts on CRISPR and its potential use in hum ans by
calling the reader' s attention to the metaphor of gene editing. This
apt metaphor suggests that gene editing is an intentional activity by
which the gene editor seeks to delete errors and insert improvements
within the biological text ofthe human genome. Gene editing, like
literary ed iting, presupposes that the editor must employ a set of
background values that guide her editing decisions . Choices hav e to
be ranked on a scale from better to worse, and there must be a rational
way to select the best changes. As my brief discussion suggests, human gene editing is a new technological power that calls into action
our deepest moral commitments and values.

10

Parfit, Derek. ( 1986). Reasons and Persons. (Ox fo rd : Oxford University Press).
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Judith Bailey

Western Michigan University

VOLUME XVI

School Desegregation 50 Years After Brown:
Misconceptions, Lessons Learned, and Hopes for the
Future
No . I, October 2005
Gary Orfield
Harvard University

Universities and Corporations: A Selection of Papers
Presented at the Western Michigan University Emeriti
Council Forum

No. 2, April 2006

Media Ethics: The Powerful and the Powerless
No.3 , April 2006
Elaine E. Englehardt
Utah Va lley State Co ll ege

Darwinism and the Meaning of Life
No. 4, May 2007
Arthur Falk

Western M ic hi gan Univers ity

VOLUME XVII

Professions: "Of A ll Professions Begging is the Best"
A Paper by Michael Davis
Response by Joseph Ellin
Professor Davis' Reply
No. I, A ugust 2008
Michael Davis

Illinois In stitute of Techno logy

Joseph Ellin

Western Michiga n University

The Moral Justification for Journalism

No . 2, December 2008
Sandra Borden

Western Michigan Uni ve rsity

A Free and Undemocratic Press?
No.3, No vember 2009
Stephen J .A. Ward

Uni ve rsity of Wisco nsin-Madi so n

VOLUME XVIII

Diversity, Democracy and Dialogue in a Human Rights
Framework

No.1 , Jun e 2010
Carol C. Gould

City Uni versity ofNew York

Center for the Study of Ethics in Society:
Celebrating 25 Years

No . 2, Jun e 20 II
Michael S. Pritchard , Shirley Bach, James A. Jaksa,
Ronald Kramer
Western Michi gan Uni vers ity

VOLUME XIX

Communication and th e Pragmatic Condition

No. 1, October 20 I I
Gregory J . Shepherd
University of Miami

Knowledge, Wisdom, and Service: Th e Meaning and
Teaching of Professionalism in Medicine
No . 2, Ma rch 20 12
Matthew K. W ynia

The Institute fo r Ethics and the Center for Pati ent Safety, American
Medical Assoc iation

VOLUME XX

Journey of Peace Journalist

No. I, March 201 3

Robert Koehler

Chi cago-based synd icated j o urnalist

VOLUME XXI

Anorexia/Bulimia, Transcendence, and the Potential
Impact of Romanticized/Sexualized Death Imagery
No. I, November2014

Heather D. Schild

Departme nt of Sociology

VOLUME XXII

Vulnerability, Preventability, and Responsibility:
Exploring Some Normative Implications of the Human
Condition

No. I, September 2015

Daniel Wueste

Rutl a nd Insti tute for Ethi cs, C lemso n Un ive rs ity

The Germans and Their Nazi Past:
To What Extent Have They Accepted Responsibility ?

No.2, April 2016

Martin Hille

University of Passau (Ge rma ny)

Spring 2016 Lecture Series
"Peace During War: The Ethics of Forgiveness"

4:00p.m. Wednesday, January 27th
3508 Knauss Hall
Michael Wilder & Yafinceio Harris, Peace During War Project
Jennifer Machiorlatti, Professor of Communication, WMU
Co-Sponsors: School of Communication

"Divorce (Professional)"

4:00 p.m. Wednesday, February 24th , & Thursday,
February 25th, 6:00 p.m.
Center for the Humanities, 2500 Knauss Hall
Written by Kathy Purnell, Research Contracts Administrator, Office
of the Vice President for Research, WMU
Directed by Laura Henderson , Founder and Executive Producer,
Queer Theater Kalamazoo
·
Co-Sponsors: Graduate College, Office of the Vice President for
Research, Department of Political Science

"Student Leadership in Academic Integrity"

4:00p.m . Tuesday, March 22'd
Brown & Gold Room, Bernhard Center
Ceceilia Parnther, doctoral candidate, Department of Educationa l
Leadership, Research, and Technology, WMU
Co-Sponsors: Visit our website: https: //wm ich.ed u/ethics

"The Biopolitical Fragmentation of Life: Lessons Still to Learn a
Decade after Schiavo"

7:00p.m. Tuesday, April 12th
Brown & Gold Room, Bernhard Center
Tyler Gibb, Assistant Professor, Program in Medical Ethics,
Humanities & Law, WM U Homer Stryker M.D. School of Medicine
Co-Sponsor: WMU Homer St ryker M.D. Sc hool of Medicine

Stay Informed About Ethics Center Events

To be on the mailing list for the WMU Center for the Study of
Ethics in Society, send us the following information:

Event Update Preference (Check one):
_E-Mail Only _Paper Mail Only _Both Paper and E-mail

Send to : Center for the Study of Ethics in SocietY
Western Michigan University
1903 West Michigan Ave.
Kalamazoo, MI 49008-5328
Or:

ethicscenter@wmich .edu

You can also find the Center on Facebook and Twitter.
The Center regularly pub! ishes papers presented as part of its lecture
series. All papers are archived on Scholar Works, accessible via the
Center' s website at http://www.wmich.edu/ethics/publications

Lithograph on Front Cover: The Oaklands, WMU

